Mustang Bio, Inc.
MBIO
$1.09
-$0.08-6.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.14M | 6.54M | 7.27M | 8.79M | 9.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.55M | 21.44M | 31.64M | 39.64M | 50.73M |
| Operating Income | -12.55M | -21.44M | -31.64M | -39.64M | -50.73M |
| Income Before Tax | -15.75M | -23.42M | -32.06M | -40.10M | -51.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.75 | -23.42 | -32.06 | -40.10 | -51.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.75M | -23.42M | -32.06M | -40.10M | -51.60M |
| EBIT | -12.55M | -21.44M | -31.64M | -39.64M | -50.73M |
| EBITDA | -11.88M | -20.53M | -30.50M | -38.24M | -48.87M |
| EPS Basic | -43.65 | -85.73 | -145.36 | -227.51 | -307.57 |
| Normalized Basic EPS | -23.06 | -50.99 | -93.42 | -148.34 | -198.38 |
| EPS Diluted | -43.65 | -85.73 | -145.36 | -227.51 | -307.57 |
| Normalized Diluted EPS | -23.06 | -50.99 | -93.42 | -148.34 | -198.38 |
| Average Basic Shares Outstanding | 2.44M | 1.62M | 1.05M | 751.30K | 688.10K |
| Average Diluted Shares Outstanding | 2.44M | 1.62M | 1.05M | 751.30K | 688.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |